Claeysen S, Faye P, Sebben M, Lemaire S, Bockaert J, Dumuis A
CNRS UPR 9023, Centre CNRS-INSERM de Pharmacologie-Endocrinologie, Montpellier, France.
Neuroreport. 1997 Oct 20;8(15):3189-96. doi: 10.1097/00001756-199710200-00002.
We have isolated a cDNA encoding the 5-HT4S receptor by RT-PCR on poly (A)+ RNA from both human heart and brain. The sequence homology with the rat and mouse 5-HT4 receptors was high: 93.8% of identity in the amino acid sequence. None of the 24 amino acid substitutions observed between rat and human receptors are at positions likely to modify their pharmacology. Comparing the pharmacological properties of six agonists and five antagonists on rat and human 5-HT4S receptors revealed no significant differences. We have analyzed the behavior of renzapride, a full and a partial agonist on mouse colliculi neurons and human heart biological responses respectively. The coupling efficiency of renzapride was two-fold lower than that of 5-HT for the stimulation of 5-HT4S receptors transfected in two different cell lines (LLC-PK1 and COS-7), but increasing the receptor density suppressed the partial agonist effect of renzapride.
我们通过逆转录聚合酶链反应(RT-PCR),从人类心脏和大脑的聚腺苷酸(poly (A)+)RNA中分离出了编码5-HT4S受体的互补DNA(cDNA)。其与大鼠和小鼠5-HT4受体的序列同源性很高:氨基酸序列的同一性达93.8%。在大鼠和人类受体之间观察到的24个氨基酸替换中,没有一个位于可能改变其药理学特性的位置。比较六种激动剂和五种拮抗剂对大鼠和人类5-HT4S受体的药理学特性,未发现显著差异。我们分别分析了renzapride在小鼠丘脑中神经元和人类心脏生物学反应中的行为,它在小鼠丘脑中神经元是完全激动剂,在人类心脏生物学反应中是部分激动剂。在两种不同细胞系(LLC-PK1和COS-7)中,转染的5-HT4S受体受刺激时,renzapride的偶联效率比5-羟色胺(5-HT)低两倍,但增加受体密度可抑制renzapride的部分激动剂效应。